NEW YORK (GenomeWeb News) – Strand Life Sciences will work with two institutes on a study in India that aims to identify and validate biomarkers for breast cancer, the Bangalore-based firm said Wednesday.

Strand will partner with the Kidwai Memorial Institute of Oncology and the Indian Institute of Science (IISc) to study more than 300 adult Indian women suffering from breast cancer in an effort to generate molecular signatures that could be used to predict response to various therapies and treatments, metastasis, relapse, and disease-free survival rates.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Hundreds of scientists have signed a letter criticizing the open-access Plan S, ScienceInsider reports.

NPR speaks with Rep. Eddie Bernice Johnson (D-Texas) about the US House of Representatives science committee.

A start-up company aiming to match cancer patients to treatments closes after about six weeks, Stat News reports.

In PLOS this week: somatic mutation associations unearthed in thousands of cancer exomes, pathogen detection assay, and more.